Archangel BioVentures, LLC is a closely
held investment company that
focuses on emerging Life Science and
Healthcare businesses.
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
understand and we often play an interim management role
in our businesses. Archangel is funded with proceeds from
the sale of Operon Technologies, Inc. to QIAGEN N.V. for
approximately $150 million in 2000. Our investors include Dr.
Bruce Ames, Dr. Robert Saul and Nathan Hamilton, who
were the three largest shareholders in Operon.
When you partner with Archangel you gain immediate
access to our extensive network of prominent scientists and
business professionals with proven track records of success. In
addition, we also provide access to our network of private
investors and venture capitalists for co-investment
opportunities.
Our portfolio companies include:
• Aspira Biosystems, Inc. (www.aspirabio.com)
• Biolog, Inc. (www.biolog.com)
• DynaTherm Medical, Inc. (www.dynathermmedical.com)
• Juvenon, Inc. (www.juvenon.com)
• Metrigen, Inc. (www.metrigen.com)
• MicroFluidic Systems, Inc. (www.mfsi.biz)